Alexander Böcker
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
- Neurology top 10%
- Barrier Structure and Function Studies
Papers in
-
- Histone Deacetylase Inhibitors Research 3
- Protein Degradation and Inhibitors 2
- Metabolomics and Mass Spectrometry Studies 2
- Receptor Mechanisms and Signaling 2
-
- Computational Drug Discovery Methods 7
- Co-authors
- Gisbert Schneider (6 shared papers)Andreas Teckentrup (3 shared papers)Ulrich M. Lauer (5 shared papers)Sascha Venturelli (5 shared papers)Michael Bitzer (3 shared papers)Christian Leischner (4 shared papers)Christian Busch (4 shared papers)Thomas S. Weiß (3 shared papers)
- Journals
- Journal of Chemical Information and Modeling (3 papers)ChemMedChem (2 papers)Cell stem cell (1 paper)SLAS DISCOVERY (1 paper)Pharmaceuticals (1 paper)
- Partner nations
- GermanyUnited StatesCanada
In The Last Decade
Alexander Böcker
20 papers receiving 779 citations
Peers
Comparison fields: 5 of 108
- Geriatrics and Gerontology 53
- Neurology 69
- Computational Theory and Mathematics 140
- Molecular Biology 452
- Pharmacology 36
Countries citing papers authored by Alexander Böcker
This map shows the geographic impact of Alexander Böcker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Böcker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Böcker more than expected).
Fields of papers citing papers by Alexander Böcker
This network shows the impact of papers produced by Alexander Böcker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Böcker. The network helps show where Alexander Böcker may publish in the future.
Co-authors
The 25 scholars most cited alongside Alexander Böcker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 148 | |
| 2 | 2012 | 101 | |
| 3 | 2015 | 84 | |
| 4 | 2012 | 79 | |
| 5 | 2012 | 62 | |
| 6 | 2005 | 49 | |
| 7 | 2012 | 45 | |
| 8 | 2010 | 35 | |
| 9 | 2004 | 31 | |
| 10 | 2018 | 27 | |
| 11 | 2006 | 26 | |
| 12 | 2008 | 26 | |
| 13 | 2007 | 22 | |
| 14 | 2022 | 16 | |
| 15 | 2015 | 15 | |
| 16 | 2011 | 13 | |
| 17 | 2007 | 10 | |
| 18 | Design for X-Guidelines and Lifecycle Phases with Relevance for Product Planning - An MDM-Based Approach | 2011 | 5 |
| 19 | 2007 | 3 | |
| 20 | 2014 | 1 |
About Alexander Böcker
Alexander Böcker is a scholar working on Molecular Biology, Computational Theory and Mathematics, Cellular and Molecular Neuroscience, Neurology and Spectroscopy, having authored 20 papers that have together received 798 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (7 papers), Histone Deacetylase Inhibitors Research (3 papers), Analytical Chemistry and Chromatography (3 papers), Protein Degradation and Inhibitors (2 papers), Barrier Structure and Function Studies (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Nuclear Receptors and Signaling (2 papers) and Receptor Mechanisms and Signaling (2 papers). The work is most often cited by research in Geriatrics and Gerontology (53 citations), Neurology (69 citations), Computational Theory and Mathematics (140 citations), Molecular Biology (452 citations) and Pharmacology (36 citations). Alexander Böcker has collaborated with scholars based in Germany, United States and Canada. Frequent co-authors include Gisbert Schneider, Andreas Teckentrup, Ulrich M. Lauer, Sascha Venturelli, Michael Bitzer, Christian Leischner, Christian Busch, Thomas S. Weiß, Timo Weiland and Seema Noor. Their work appears in journals such as Journal of Chemical Information and Modeling, ChemMedChem, Cell stem cell, SLAS DISCOVERY and Pharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.